Summary
This two-arm clinical study, published in Nutrients (2022), investigates whether regular consumption of food biofortified with molybdenum can beneficially influence glucose homeostasis in human subjects. Molybdenum is a trace element involved in key enzymatic processes, and biofortification represents a dietary strategy to address micronutrient insufficiency. The study contributes to the emerging evidence base on targeted mineral biofortification as a feasible nutritional intervention for metabolic health outcomes.
UK applicability
The findings are not directly derived from UK populations but are potentially applicable to UK dietary and public health contexts, where interest in biofortification strategies as cost-effective micronutrient interventions is growing. UK policymakers and nutritionists may find the glucose homeostasis data relevant given the prevalence of type 2 diabetes and metabolic syndrome.
Key measures
Blood glucose levels (mmol/L); insulin concentrations; HOMA-IR or similar insulin resistance indices; molybdenum dietary intake or serum levels
Outcomes reported
The study examined the effect of consuming molybdenum-biofortified food on markers of glucose homeostasis in human participants across two study arms. It likely reported fasting glucose, insulin, and related metabolic parameters before and after dietary intervention.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.